Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial

Autor: Koole, Simone N., Schouten, Philip C., Hauke, Jan, Kluin, Roel J. C., Nederlof, Petra, Richters, Lisa K., Krebsbach, Gabriele, Sikorska, Karolina, Alkemade, Maartje, Opdam, Mark, van Leeuwen, Jules H. Schagen, Schreuder, Henk W. R., Hermans, Ralph H. M., de Hingh, Ignace H. J. T., Mom, Constantijne H., Arts, Henriette J. G., van Ham, Maaike, van Dam, Peter, Vuylsteke, Peter, Sanders, Joyce, Horlings, Hugo M., van de Vijver, Koen K., Hahnen, Eric, van Driel, Willemien J., Schmutzler, Rita, Sonke, Gabe S., Linn, Sabine C.

Publikováno v: Koole, S N, Schouten, P C, Hauke, J, Kluin, R J C, Nederlof, P, Richters, L K, Krebsbach, G, Sikorska, K, Alkemade, M, Opdam, M, Schagen van Leeuwen, J H, Schreuder, H W R, Hermans, R H M, de Hingh, I H J T, Mom, C H, Arts, H J G, van Ham, M, van Dam, P, Vuylsteke, P, Sanders, J, Horlings, H M, van de Vijver, K K, Hahnen, E, van Driel, W J, Schmutzler, R, Sonke, G S & Linn, S C 2022, ' Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer : Results from the phase III OVHIPEC trial ', International Journal of Cancer, vol. 151, no. 8, pp. 1394-1404 . https://doi.org/10.1002/ijc.34124
International Journal of Cancer, 151, 1394-1404
International Journal of Cancer, 151, 8, pp. 1394-1404
International journal of cancer
International Journal of Cancer, 151(8), 1394-1404. Wiley-Liss Inc.
International Journal of Cancer, 151(8), 1394-1404. Wiley

Contains fulltext : 282977.pdf (Publisher’s version ) (Closed access) The addition of hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin to interval cytoreductive surgery improves recurrence-free (RFS) and overall survival (OS) in pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5868956c55119e7ddaf220e8683d6ea8
https://hdl.handle.net/2066/282977